English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/40652
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorCordero, Mario D.-
dc.contributor.authorMoreno-Fernández, Ana M.-
dc.contributor.authorMiguel, Manuel de-
dc.contributor.authorBonal, Pablo-
dc.contributor.authorCampa, Francisco-
dc.contributor.authorJiménez-Jiménez, L. M.-
dc.contributor.authorRuiz-Losada, A.-
dc.contributor.authorSánchez-Domínguez, Benito-
dc.contributor.authorSánchez-Alcázar, José Antonio-
dc.contributor.authorSalviati, Leonardo-
dc.contributor.authorNavas, Plácido-
dc.date.accessioned2011-10-06T06:37:15Z-
dc.date.available2011-10-06T06:37:15Z-
dc.date.issued2008-11-25-
dc.identifier.citationClinical Biochemistry - New York 42(7-8): 732-735 (2009)es_ES
dc.identifier.issn0009-9120-
dc.identifier.otherPMID: 19133251-
dc.identifier.urihttp://hdl.handle.net/10261/40652-
dc.description4 páginas, 1 figura.es_ES
dc.description.abstractObjective: Coenzyme Q10 (CoQ10) is an essential electron carrier in the mitochondrial respiratory chain and a strong antioxidant. Signs and symptoms associated with muscular alteration and mitochondrial dysfunction, including oxidative stress, have been observed in patients with fibromyalgia (FM). The aim was to study CoQ10 levels in plasma and mononuclear cells, and oxidative stress in FM patients. Methods: We studied CoQ10 level by HPLC in plasma and peripheral mononuclear cells obtained from patients with FM and healthy control subjects. Oxidative stress markers were analyzed in both plasma and mononuclear cells from FM patients. Results: Higher level of oxidative stress markers in plasma was observed respect to control subjects. CoQ10 level in plasma samples from FM patients was doubled compared to healthy controls and in blood mononuclear cells isolated from 37 FM patients was found to be about 40% lower. Higher levels of ROS production was observed in mononuclear cells from FM patients compared to control, and a significant decrease was induced by the presence of CoQ10. Conclusion: The distribution of CoQ10 in blood components was altered in FM patients. Also, our results confirm the oxidative stress background of this disease probably due to a defect on the distribution and metabolism of CoQ10 in cells and tissues. The protection caused in mononuclear cells by CoQ10 would indicate the benefit of its supplementation in FM patients.es_ES
dc.description.sponsorshipThis work was supported by Spanish MEC BFU2005-03017 grant.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.publisherCanadian Society of Clinical Chemistses_ES
dc.rightsclosedAccesses_ES
dc.subjectCoenzyme Q10es_ES
dc.subjectFibromyalgiaes_ES
dc.subjectMononuclear cellses_ES
dc.subjectOxidative stresses_ES
dc.subjectMalondialdehydees_ES
dc.subjectUbiquinonees_ES
dc.subjectReactive oxygen specieses_ES
dc.titleCoenzyme Q10 distribution in blood is altered in patients with Fibromyalgiaes_ES
dc.typeArtículoes_ES
dc.identifier.doi10.1016/j.clinbiochem.2008.12.010-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://dx.doi.org/10.1016/j.clinbiochem.2008.12.010es_ES
Appears in Collections:(CABD) Artículos
Files in This Item:
There are no files associated with this item.
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.